Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Biosimilars'

Biosimilars published presentations and documents on DocSlides.

Distinguishable INNs: A Global Solution

Distinguishable INNs: A Global Solution

  • trish-goza
  • 23 Slides

Richard . Dolinar. , MD. Chairman, Alliance for S...

Interchangeable Biosimilars: The Future of Affordable MedicineFDA is i

Interchangeable Biosimilars: The Future of Affordable MedicineFDA is i

  • celsa-spraggs
  • 100 Slides

Interchangeability = SubstitutabilityInterchangeab...

Biosimilars: Additional Questions and Answers Regarding Implementatio

Biosimilars: Additional Questions and Answers Regarding Implementatio

  • liane-varnes
  • 100 Slides

&#x/Att;¬he; [/; ott;&#xom ];&#x/BBo...

Biosimilars: Additional Questions and Answers Regarding Implementatio

Biosimilars: Additional Questions and Answers Regarding Implementatio

  • mitsue-stanley
  • 100 Slides

&#x/Att;¬he; [/; ott;&#xom ];&#x/BBo...

Biosimilars: Questions and Answers Regarding Implementation of the Bi

Biosimilars: Questions and Answers Regarding Implementation of the Bi

  • danika-pritchard
  • 100 Slides

&#x/Att;¬he; [/; ott;&#xom ];&#x/BBo...

Biosimilars: Questions and Answers Regarding Implementation of the Bi

Biosimilars: Questions and Answers Regarding Implementation of the Bi

  • sherrill-nordquist
  • 100 Slides

&#x/Att;¬he; [/; ott;&#xom ];&#x/BBo...

Roche Position

Roche Position

  • faustina-dinatale
  • 100 Slides

1 1 on Similar Biotherapeutic Products – B...

A QUM partnership approach to regulating

A QUM partnership approach to regulating

  • liane-varnes
  • 18 Slides

biosimilars. in Australia. David Lim, Evan Siege...

Biosimilars in the united states – Update on FDA Impleme

Biosimilars in the united states – Update on FDA Impleme

  • test
  • 37 Slides

James C. Shehan. Hyman, Phelps & McNamara, P....

Phil Johnson MS

Phil Johnson MS

  • stefany-barnette
  • 56 Slides

RPh. Safe School Meds, Principle Partner. Moffitt...

Latin American Biologics/Biosimilars Conference

Latin American Biologics/Biosimilars Conference

  • giovanna-bartolotta
  • 13 Slides

Presented by . the Alliance for Safe Bioloigic . ...

Acceptable changes in quality attributes of glycosylated bi

Acceptable changes in quality attributes of glycosylated bi

  • debby-jeon
  • 19 Slides

Schiestl M, Stangler T, Torella C, et al. . Nat B...

Biosimilars

Biosimilars

  • lindy-dunigan
  • 22 Slides

Knowledge Connect Slide Resource. This slide dec...

ASBM Biosimilars

ASBM Biosimilars

  • phoebe-click
  • 38 Slides

US Prescribers and Biosimilars Naming. Kevin Olso...

Biosimilars in RA: A Blessing or a Curse?

Biosimilars in RA: A Blessing or a Curse?

  • conchita-marotz
  • 0 Slides

Introduction/Overview . What Is a Biosimilar?. Di...

US Regulatory Pathway For Biosimilars

US Regulatory Pathway For Biosimilars

  • cheryl-pisano
  • 0 Slides

Practical Legal/Regulatory Considerations Arising...

Biosimilars 2012 AIPLA Webinar

Biosimilars 2012 AIPLA Webinar

  • stefany-barnette
  • 0 Slides

September 25, 2012. 1. Denise. Kettelberger, PhD...

Biosimilars in the Real World

Biosimilars in the Real World

  • liane-varnes
  • 0 Slides

Introduction/Overview . PLANETRA Extension Study:...

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

  • calandra-battersby
  • 0 Slides

OMICS Group Biosimilars 2015 Birmingham, UK. 10-1...

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

  • stefany-barnette
  • 0 Slides

OMIC Group Biosimilars 2014. Hyderabad India. 27-...

Understanding Biologics Biologics and Biosimilars

Understanding Biologics Biologics and Biosimilars

  • calandra-battersby
  • 0 Slides

Animation: What Are Biologics?. Production of Bio...

Biological Products: concepts, naming,

Biological Products: concepts, naming,

  • faustina-dinatale
  • 0 Slides

interchangeability,extrapolation. and safety. Dr...

Faculty Leonard H. Calabrese, DO

Faculty Leonard H. Calabrese, DO

  • trish-goza
  • 0 Slides

Professor of Medicine. Cleveland Clinic Lerner Co...

Applying Biosimilars in Hematologic Cancers

Applying Biosimilars in Hematologic Cancers

  • conchita-marotz
  • 0 Slides

This program will include a discussion of off-lab...

United Spinal Association

United Spinal Association

  • alida-meadow
  • 0 Slides

August, 2014. Biologics & Biosimilars: . An O...

Comparison of US/EU Biosimilar

Comparison of US/EU Biosimilar

  • danika-pritchard
  • 0 Slides

Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...

Biosimilars & EU regulation

Biosimilars & EU regulation

  • karlyn-bohler
  • 0 Slides

Alice DOMINIQUE - M2 AREIPS. 1. Content. 2. Defin...

Biosimilars: Regulation and Litigation

Biosimilars: Regulation and Litigation

  • mitsue-stanley
  • 0 Slides

Agenda. Key Regulatory Exclusivities for Biologic...

About OMICS Group OMICS Group International is an amalgamation of 

About OMICS Group OMICS Group International is an amalgamation of 

  • sherrill-nordquist
  • 0 Slides

Open Access publications.  and worldwide interna...

ASBM Biosimilars US Prescribers and Biosimilars Naming

ASBM Biosimilars US Prescribers and Biosimilars Naming

  • min-jolicoeur
  • 0 Slides

Kevin Olson, CEO. Industry Standard Research. Kev...

PhAMA Position on Biosimilar Medicines

PhAMA Position on Biosimilar Medicines

  • celsa-spraggs
  • 0 Slides

Ms. Leah Goodman. Contents. Key Messages. An Over...

Biosimilars Guideline – a Summary of the Industry Comments

Biosimilars Guideline – a Summary of the Industry Comments

  • marina-yarberry
  • 0 Slides

M Bredenhann | Nycomed | 19.11.10. BIOSIMILAR...

Application of Biosimilars in RA IN Clinical Practice:

Application of Biosimilars in RA IN Clinical Practice:

  • conchita-marotz
  • 0 Slides

Key Issues and Challenges.  . Introduction. Diff...

Comparison of US/EU Biosimilar

Comparison of US/EU Biosimilar

  • myesha-ticknor
  • 0 Slides

Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...

U.S. Biosimilars: An Introduction

U.S. Biosimilars: An Introduction

  • calandra-battersby
  • 0 Slides

Disclaimers. :. By 2016, 7 of the top 10 pharmace...

Bio similars A Presentation

Bio similars A Presentation

  • kittie-lecroy
  • 0 Slides

By. ANSHUL . SHARMA. Graduate Research Scholar. D...

Biosimilars are effective and safe and should immediately replace innovator molecules in the NHS

Biosimilars are effective and safe and should immediately replace innovator molecules in the NHS

  • myesha-ticknor
  • 0 Slides

Dr Chris Deighton. Consultant Rheumatologist . Co...

Comparison of US/EU Biosimilar

Comparison of US/EU Biosimilar

  • aaron
  • 0 Slides

Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...

Phil Johnson MS RPh Safe School Meds, Principle Partner

Phil Johnson MS RPh Safe School Meds, Principle Partner

  • yoshiko-marsland
  • 0 Slides

Moffitt Cancer Center, Director of Pharmacy (Reti...

Latin American Physician Perspectives on Biosimilars

Latin American Physician Perspectives on Biosimilars

  • celsa-spraggs
  • 0 Slides

Presented at the . Latin American Biologics/Biosi...

Copyright © 2024 DocSlides. All Rights Reserved